Skip to content

Discussion on the Pathogenesis of Trigeminal Neuralgia

Discussion on the Pathogenesis of Trigeminal Neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109942
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-09-28
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia

Interventions

Part 1: Case Group Undergoing percutaneous balloon Compression:None
Part 2: Case Group of Primary Trigeminal Neuralgia:None
Part 2: Healthy Control Group:None

Sponsors

The Second Hospital of Hebei Midical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: Part 1: meeting the diagnostic criteria of primary trigeminal neuralgia; Cranial MRI was performed to exclude space-occupying lesions. 30 years <= age <=90 years; 7 points <=VAS score <=10 points. Part 2:30 years <= age <=90 years; There was no chronic pain disorder.

Exclusion criteria

Exclusion criteria: Part 1: Uncooperative patients; Abnormal blood clotting. Part 2: Uncooperative.

Design outcomes

Primary

MeasureTime frame
Tumor necrosis factor;Interleukin;Brain-derived growth factor;Glial Cell Line-Derived Neurotrophic Factor;S100ß Protein;Glial Fibrillary Acidic Protein;p38mapk;Neuron-specific enolase;

Countries

China

Contacts

Public ContactLiqin Gao

The Second Hospital of Hebei Midical University

18203212623@163.com+86 311 6600 3717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026